Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for Pediatric OCD
NCT01172275Phase 2Completed
- Sponsor
- Yale University
- Start
- Jul 2012
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in obsessive compulsive disorder (OCD), sponsored by Yale University. Started Jul 2012; status: completed.
02
Drugs
acetylcysteine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT01172275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01172275.